Caption Management, LLC Kezar Life Sciences, Inc. Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.08 - $2.54 $166,936 - $392,610	154,571 Added 738.34%	175,506 $208,000
Q2 2023 Aug 14, 2023	BUY	$2.31 - $3.06 $48,359 - $64,061	20,935 New	20,935 $51,000
Q3 2022 Nov 14, 2022	SELL	$7.99 - $10.75 $329,811 - $443,738	-41,278 Reduced 96.95%	1,300 $11,000
Q2 2022 Aug 15, 2022	BUY	$4.58 - $17.13 $158,367 - $592,321	34,578 Added 432.23%	42,578 $352,000
Q1 2022 May 13, 2022	BUY	$12.3 - $18.33 $98,400 - $146,640	8,000 New	8,000 $133,000

37.3M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $443M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.